NADOFARAGENE FIRADENOVEC-VNCG

NADOFARAGENE FIRADENOVEC-VNCG was reported 523 times

NADOFARAGENE FIRADENOVEC-VNCG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INSTILLATION SITE DISCHARGE 107 0.4068
1 FLUORESCENT IN SITU HYBRIDISATION POSITIVE 1 0.1000
2 CYSTOSCOPY ABNORMAL 3 0.0652
3 RADICAL CYSTECTOMY 2 0.0571
4 EXPULSION OF MEDICATION 25 0.0473
5 METASTASES TO TRACHEA 1 0.0357
6 BLADDER SPASM 62 0.0331
7 URINE CYTOLOGY ABNORMAL 1 0.0303
8 CYTOLOGY ABNORMAL 4 0.0267
9 URINARY CYSTECTOMY 3 0.0254
10 CARCINOMA IN SITU 3 0.0180
11 TRANSITIONAL CELL CARCINOMA RECURRENT 1 0.0172
12 URINARY SEDIMENT 1 0.0172
13 INSTILLATION SITE DISCOMFORT 2 0.0149
14 BLADDER CANCER RECURRENT 13 0.0130
15 BLADDER PAPILLOMA 1 0.0128
16 CLINICALLY ISOLATED SYNDROME 1 0.0105
17 PNEUMATURIA 1 0.0104
18 COLD FLASH 1 0.0086
19 SEPTIC ENCEPHALOPATHY 1 0.0058
20 LOWER URINARY TRACT SYMPTOMS 2 0.0055
21 PNEUMONIA ADENOVIRAL 1 0.0051
22 NORMOCHROMIC ANAEMIA 1 0.0050
23 BLADDER DISCOMFORT 6 0.0048
24 SPINAL CORD HAEMATOMA 1 0.0047
25 URINARY TRACT DISCOMFORT 2 0.0043
26 BLADDER NEOPLASM 7 0.0041
27 BLADDER IRRITATION 2 0.0031
28 ANION GAP DECREASED 1 0.0029
29 MICTURITION URGENCY 29 0.0025
30 INSTILLATION SITE IRRITATION 3 0.0025
31 CITROBACTER INFECTION 1 0.0023
32 BLADDER OBSTRUCTION 1 0.0019
33 SCROTAL PAIN 1 0.0019
34 GENITAL DISCOMFORT 1 0.0018
35 NEOPLASM RECURRENCE 5 0.0015
36 CYTOKINE STORM 1 0.0015
37 EXPOSURE VIA BODY FLUID 1 0.0013
38 TONGUE PRURITUS 1 0.0012
39 GENITAL BURNING SENSATION 1 0.0012
40 URGE INCONTINENCE 1 0.0011
41 URINARY TRACT INFECTION ENTEROCOCCAL 1 0.0011
42 KLEBSIELLA BACTERAEMIA 1 0.0011
43 DISEASE RECURRENCE 48 0.0010
44 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
45 LABILE BLOOD PRESSURE 1 0.0008
46 PHARYNGEAL HAEMORRHAGE 1 0.0008
47 INCONTINENCE 8 0.0008
48 CYSTITIS NONINFECTIVE 1 0.0007
49 CALCULUS BLADDER 1 0.0007
50 VIRAEMIA 1 0.0007
51 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
52 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
53 ADENOVIRUS INFECTION 2 0.0007
54 INCORRECT PRODUCT ADMINISTRATION DURATION 14 0.0006
55 MEAN CELL HAEMOGLOBIN INCREASED 1 0.0006
56 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
57 DYSURIA 21 0.0006
58 HAEMATURIA 19 0.0006
59 BODY TEMPERATURE FLUCTUATION 1 0.0005
60 BLOOD URINE PRESENT 9 0.0005
61 URINE OUTPUT DECREASED 4 0.0005
62 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
63 URINE FLOW DECREASED 1 0.0004
64 CATHETER SITE HAEMORRHAGE 1 0.0004
65 URINARY TRACT INFECTION BACTERIAL 1 0.0004
66 VULVOVAGINAL PRURITUS 2 0.0004
67 HAEMORRHAGE URINARY TRACT 1 0.0004
68 MEAN CELL VOLUME INCREASED 1 0.0004
69 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
70 POLLAKIURIA 14 0.0003
71 BLADDER PAIN 1 0.0003
72 LOSS OF THERAPEUTIC RESPONSE 1 0.0003
73 BLOOD CREATININE ABNORMAL 1 0.0003
74 MICTURITION DISORDER 1 0.0003
75 INFLUENZA LIKE ILLNESS 22 0.0003
76 SPINAL CORD COMPRESSION 1 0.0003
77 SKIN ODOUR ABNORMAL 1 0.0003
78 CYSTITIS HAEMORRHAGIC 1 0.0002
79 RECURRENT CANCER 1 0.0002
80 URINARY INCONTINENCE 7 0.0002
81 MUSCLE FATIGUE 1 0.0002
82 BONE CANCER 1 0.0002
83 VULVOVAGINAL DISCOMFORT 1 0.0002
84 ANAL INCONTINENCE 2 0.0002
85 URINARY TRACT DISORDER 1 0.0002
86 CHILLS 26 0.0002
87 FLANK PAIN 2 0.0002
88 FAILURE TO THRIVE 1 0.0002
89 BRAIN FOG 3 0.0002
90 POLYARTHRITIS 1 0.0002
91 VULVOVAGINAL BURNING SENSATION 1 0.0002
92 METASTASIS 1 0.0001
93 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
94 DISEASE PROGRESSION 15 0.0001
95 CYSTITIS 4 0.0001
96 POLYURIA 1 0.0001
97 URINARY RETENTION 4 0.0001
98 ABDOMINAL PAIN LOWER 3 0.0001
99 PYREXIA 40 0.0001
100 DISCOMFORT 7 0.0001
101 FACIAL PAIN 1 0.0001
102 THERAPY NON-RESPONDER 5 0.0001
103 LIP DRY 1 0.0001
104 OPTIC NEURITIS 1 0.0001
105 UROSEPSIS 1 0.0001
106 MENTAL STATUS CHANGES 3 0.0001
107 PERSONALITY CHANGE 1 0.0001
108 HEPATOMEGALY 1 0.0001
109 THERAPY CHANGE 1 0.0001
110 BLADDER DISORDER 1 0.0001
111 NEUTROPHIL COUNT INCREASED 1 0.0001
112 EAR DISCOMFORT 1 0.0001
113 SUDDEN DEATH 1 0.0001
114 RENAL PAIN 1 0.0001
115 BLOOD CALCIUM DECREASED 1 0.0001
116 NEOPLASM 1 0.0001
117 POST PROCEDURAL HAEMORRHAGE 1 0.0001
118 BURNING SENSATION 6 0.0001
119 NOCTURIA 1 0.0001
120 ENCEPHALOPATHY 2 0.0001
121 AGEUSIA 2 0.0001
122 UNRESPONSIVE TO STIMULI 2 0.0001
123 BEDRIDDEN 1 0.0001
124 DISORIENTATION 3 0.0001
125 ADVERSE REACTION 1 0.0001
126 TREATMENT FAILURE 6 0.0001
127 MASS 1 0.0001
128 BLINDNESS UNILATERAL 1 0.0001
129 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
130 ANOSMIA 1 0.0001
131 LYMPHOMA 1 0.0001
132 MUSCULOSKELETAL CHEST PAIN 1 0.0001
133 ANKLE FRACTURE 1 0.0001
134 METASTASES TO BONE 1 0.0001
135 EXPIRED PRODUCT ADMINISTERED 2 0.0001
136 GAIT INABILITY 2 0.0001
137 BLOOD UREA INCREASED 1 0.0001
138 PERICARDITIS 1 0.0001
139 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
140 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
141 ORTHOSTATIC HYPOTENSION 1 0.0001
142 SYRINGE ISSUE 1 0.0001
143 ISCHAEMIC STROKE 1 0.0001
144 PANCYTOPENIA 3 0.0001
145 BLOOD SODIUM DECREASED 1 0.0001
146 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
147 POST PROCEDURAL COMPLICATION 1 0.0001
148 UPPER LIMB FRACTURE 1 0.0001
149 PRODUCT ADMINISTRATION ERROR 1 0.0000
150 INJURY ASSOCIATED WITH DEVICE 1 0.0000
151 BODY TEMPERATURE INCREASED 1 0.0000
152 PRODUCT PREPARATION ERROR 1 0.0000
153 IRRITABLE BOWEL SYNDROME 1 0.0000
154 BLOOD CREATININE INCREASED 3 0.0000
155 FATIGUE 35 0.0000
156 SEPSIS 5 0.0000
157 PRODUCT AVAILABILITY ISSUE 1 0.0000
158 INCORRECT DOSE ADMINISTERED 10 0.0000
159 CARDIAC DISORDER 4 0.0000
160 SLEEP DISORDER 3 0.0000
161 PRESYNCOPE 1 0.0000
162 PRODUCT COMPLAINT 1 0.0000
163 DECREASED APPETITE 9 0.0000
164 EXPOSURE VIA SKIN CONTACT 1 0.0000
165 PROCEDURAL PAIN 1 0.0000
166 FEELING COLD 1 0.0000
167 HYPONATRAEMIA 2 0.0000
168 RED BLOOD CELL COUNT DECREASED 1 0.0000
169 HYPERSOMNIA 1 0.0000
170 LETHARGY 2 0.0000
171 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
172 DYSSTASIA 1 0.0000
173 BLADDER CANCER 2 0.0000
174 BLOOD POTASSIUM DECREASED 1 0.0000
175 LACRIMATION INCREASED 1 0.0000
176 HOSPITALISATION 5 0.0000
177 HEAD INJURY 1 0.0000
178 NEUROPATHY PERIPHERAL 3 0.0000
179 DRUG INTOLERANCE 3 0.0000
180 RHINORRHOEA 2 0.0000
181 PAIN 19 0.0000
182 SYNCOPE 3 0.0000
183 ASTHENIA 11 0.0000
184 DEATH 25 0.0000
185 WEIGHT DECREASED 8 0.0000
186 LYMPHADENOPATHY 1 0.0000
187 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5 0.0000
188 MUSCLE SPASMS 5 0.0000
189 DYSARTHRIA 1 0.0000
190 HOT FLUSH 2 0.0000
191 CONFUSIONAL STATE 4 0.0000
192 EXTRA DOSE ADMINISTERED 1 0.0000
193 DYSKINESIA 1 0.0000
194 TREMOR 4 0.0000
195 HEADACHE 15 0.0000
196 URINARY TRACT INFECTION 4 0.0000
197 LIVER DISORDER 1 0.0000
198 TACHYCARDIA 2 0.0000
199 ADVERSE DRUG REACTION 2 0.0000
200 ADVERSE EVENT 2 0.0000
201 VOMITING 10 0.0000
202 ATRIAL FIBRILLATION 2 0.0000
203 HEART RATE INCREASED 2 0.0000
204 DRUG INEFFECTIVE 26 0.0000
205 FLUSHING 2 0.0000
206 FLUID RETENTION 1 0.0000
207 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
208 THERAPY CESSATION 1 0.0000
209 ILLNESS 2 0.0000
210 ABDOMINAL DISTENSION 2 0.0000
211 TREATMENT NONCOMPLIANCE 1 0.0000
212 MYALGIA 3 0.0000
213 DIARRHOEA 11 0.0000
214 PRODUCT USE ISSUE 3 0.0000
215 HYPERHIDROSIS 2 0.0000
216 DEEP VEIN THROMBOSIS 1 0.0000
217 NAUSEA 12 0.0000
218 DEHYDRATION 2 0.0000
219 DRY SKIN 2 0.0000
220 MOBILITY DECREASED 1 0.0000
221 INFECTION 2 0.0000
222 UNDERDOSE 1 0.0000
223 DYSGEUSIA 1 0.0000
224 UNEVALUABLE EVENT 1 0.0000
225 ACUTE KIDNEY INJURY 2 0.0000
226 ARTHRITIS 1 0.0000
227 DRY MOUTH 1 0.0000
228 CARDIAC ARREST 1 0.0000
229 RENAL IMPAIRMENT 1 0.0000
230 PRODUCT STORAGE ERROR 1 0.0000
231 GAIT DISTURBANCE 2 0.0000
232 DIZZINESS 5 0.0000
233 CHEST DISCOMFORT 1 0.0000
234 ERYTHEMA 2 0.0000
235 MALAISE 4 0.0000
236 FALL 3 0.0000
237 MUSCULAR WEAKNESS 1 0.0000
238 SEIZURE 1 0.0000
239 PALPITATIONS 1 0.0000
240 FEELING ABNORMAL 2 0.0000
241 JOINT SWELLING 1 0.0000
242 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
243 LOSS OF CONSCIOUSNESS 1 0.0000
244 VISION BLURRED 1 0.0000
245 ARTHRALGIA 3 0.0000
246 BLOOD PRESSURE INCREASED 1 0.0000
247 PNEUMONIA 2 0.0000
248 URTICARIA 1 0.0000
249 ABDOMINAL DISCOMFORT 1 0.0000
250 NASOPHARYNGITIS 1 0.0000
251 HYPERSENSITIVITY 1 0.0000
252 BLOOD GLUCOSE INCREASED 1 0.0000
253 DYSPNOEA 3 0.0000
254 ALOPECIA 1 0.0000
255 HYPOTENSION 1 0.0000
256 RASH 2 0.0000
257 CONSTIPATION 1 0.0000
258 BACK PAIN 1 0.0000
259 ABDOMINAL PAIN 1 0.0000
260 INSOMNIA 1 0.0000
261 PAIN IN EXTREMITY 1 0.0000
262 PRURITUS 1 0.0000
263 OFF LABEL USE 2 0.0000